Work

Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time.

Year: 2019

Type: review

Source: PubMed

Authors: Dickran Kazandjian, Ola Landgren

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2994123906

FWCI: 0.359

Cites: 74

Cited by: 13

Related to: 10